PT-141 (Bremelanotide) 10mg is a highly purified synthetic cyclic heptapeptide engineered for advanced laboratory research. Functioning as a non-selective agonist of the melanocortin receptors (primarily MC3R and MC4R), this compound is utilized in vitro to investigate central nervous system signaling pathways and the broader physiological roles of the melanocortin system.
This 10mg lyophilized preparation provides a robust, stable supply for comprehensive molecular investigations, allowing researchers to accurately map receptor binding dynamics, intracellular signaling cascades, and specific neurobiological responses.
Key Specifications:
Classification: Synthetic Cyclic Heptapeptide / Melanocortin Receptor Agonist
Mechanism of Action: Agonism of MC3 and MC4 receptors
Application: Laboratory research and in vitro cellular studies
Quantity: 10mg per vial
(Note: This product is strictly for research purposes only and is not intended for human or animal consumption, diagnostic, or therapeutic use.)